[HTML][HTML] The skin prick test–European standards
L Heinzerling, A Mari, KC Bergmann… - Clinical and translational …, 2013 - Springer
Skin prick testing is an essential test procedure to confirm sensitization in IgE-mediated
allergic disease in subjects with rhinoconjunctivitis, asthma, urticaria, anapylaxis, atopic …
allergic disease in subjects with rhinoconjunctivitis, asthma, urticaria, anapylaxis, atopic …
[HTML][HTML] Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts
Background Multiple studies have compared the performance of artificial intelligence (AI)–
based models for automated skin cancer classification to human experts, thus setting the …
based models for automated skin cancer classification to human experts, thus setting the …
Myocarditis in the setting of cancer therapeutics: proposed case definitions for emerging clinical syndromes in cardio-oncology
Recent developments in cancer therapeutics have improved outcomes but have also been
associated with cardiovascular complications. Therapies harnessing the immune system …
associated with cardiovascular complications. Therapies harnessing the immune system …
Myocarditis in patients treated with immune checkpoint inhibitors
Background: Myocarditis is an uncommon, but potentially fatal, toxicity of immune checkpoint
inhibitors (ICI). Myocarditis after ICI has not been well characterized. Objectives: The authors …
inhibitors (ICI). Myocarditis after ICI has not been well characterized. Objectives: The authors …
[HTML][HTML] Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
L Hofmann, A Forschner, C Loquai… - European journal of …, 2016 - Elsevier
Background Anti-programmed cell death receptor-1 (PD-1) antibodies represent an effective
treatment option for metastatic melanoma as well as for other cancer entities. They act via …
treatment option for metastatic melanoma as well as for other cancer entities. They act via …
[HTML][HTML] Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
L Zimmer, SM Goldinger, L Hofmann, C Loquai… - European journal of …, 2016 - Elsevier
Background Anti-programmed cell death 1 (PD-1) antibodies represent an effective
treatment option for metastatic melanoma and other cancer entities. They act via blockade of …
treatment option for metastatic melanoma and other cancer entities. They act via blockade of …
Baseline biomarkers for outcome of melanoma patients treated with pembrolizumab
B Weide, A Martens, JC Hassel, C Berking… - Clinical Cancer …, 2016 - AACR
Purpose: Biomarkers for outcome after immune-checkpoint blockade are strongly needed as
these may influence individual treatment selection or sequence. We aimed to identify …
these may influence individual treatment selection or sequence. We aimed to identify …
[HTML][HTML] The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network
CJ Voskens, SM Goldinger, C Loquai, C Robert… - PloS one, 2013 - journals.plos.org
Background Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody,
has been approved for the treatment of metastatic melanoma and induces adverse events …
has been approved for the treatment of metastatic melanoma and induces adverse events …
[HTML][HTML] Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
L Heinzerling, PA Ott, FS Hodi, AN Husain… - … for immunotherapy of …, 2016 - Springer
Immune-checkpoint blocking antibodies have demonstrated objective antitumor responses
in multiple tumor types including melanoma, non-small cell lung cancer (NSCLC), and renal …
in multiple tumor types including melanoma, non-small cell lung cancer (NSCLC), and renal …
[HTML][HTML] Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task
Background Recent studies have successfully demonstrated the use of deep-learning
algorithms for dermatologist-level classification of suspicious lesions by the use of excessive …
algorithms for dermatologist-level classification of suspicious lesions by the use of excessive …